Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection

被引：4
|
作者：
Einsiedel, Hagen Graf [1 ]
Christiansen, Holger [1 ]
Wiegand, Johannes [2 ]
机构：
[1] Univ Leipzig, Abt Padiat Onkol Hamatol & Hamostaseol, Leipzig, Germany
[2] Univ Leipzig, Klin & Poliklin Gastroenterol & Rheumatol, Sekt Hepatol, Liebigstr 20, D-04103 Leipzig, Germany
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2016年 / 35卷 / 12期
关键词：
D O I：
10.1097/INF.0000000000001336
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1373 / 1373
页数：1
相关论文
共 50 条
  • [1] Eight Weeks of Ledipasvir/Sofosbuvir Is Effective for Selected Patients With Genotype 1 Hepatitis C Virus Infection
    Kowdley, Kris V.
    Sundaram, Vinay
    Jeon, Christie Y.
    Qureshi, Kamran
    Latt, Nyan L.
    Sahota, Amandeep
    Lott, Stephen
    Curry, Michael P.
    Tsai, Naoky
    Chaiyakunapruk, Nathorn
    Lee, Yoori
    Petersen, Jorg
    Buggisch, Peter
    HEPATOLOGY, 2017, 65 (04) : 1094 - 1103
  • [2] Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection
    Colombo, Massimo
    Aghemo, Alessio
    Liu, Hong
    Zhang, Jie
    Dvory-Sobol, Hadas
    Hyland, Robert
    Yun, Chohee
    Massetto, Benedetta
    Brainard, Diana M.
    McHutchison, John G.
    Bourliere, Marc
    Peck-Radosavljevic, Markus
    Manns, Michael
    Pol, Stanislas
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (02) : 109 - +
  • [3] Ledipasvir Plus Sofosbuvir for 12 Weeks in Patients With Hepatitis C Genotype 4 Infection
    Abergel, Armand
    Metivier, Sophie
    Samuel, Didier
    Jiang, Deyuan
    Kersey, Kathryn
    Pang, Phillip S.
    Svarovskaia, Evguenia
    Knox, Steven J.
    Loustaud-Ratti, Veronique
    Asselah, Tarik
    HEPATOLOGY, 2016, 64 (04) : 1049 - 1056
  • [4] Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
    Sundaram, Vinay
    Kowdley, Kris V.
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2016, 8 : 75 - 80
  • [5] Ledipasvir/Sofosbuvir in the Treatment of Hepatitis C Virus Genotype 6
    Nguyen, Andrew A.
    Weisberg, Ilan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S368 - S368
  • [6] Ledipasvir-sofosbuvir for hepatitis C genotype 4 infection
    Smith, Michael A.
    Mohammad, Rima A.
    LANCET INFECTIOUS DISEASES, 2015, 15 (09): : 993 - 995
  • [7] Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients
    Abdelaty, Lamiaa N.
    Elnaggar, Ahmed A.
    Said, Amira A.
    Hussein, Raghda R. S.
    CURRENT DRUG SAFETY, 2020, 15 (01) : 53 - 60
  • [8] LEDIPASVIR/SOFOSBUVIR FIXED-DOSE COMBINATION FOR TREATMENT OF HEPATITIS C VIRUS GENOTYPE 4 INFECTION
    Nehra, V.
    Tan, E. M.
    Rizza, S. A.
    Temesgen, Z.
    DRUGS OF TODAY, 2016, 52 (02) : 111 - 117
  • [9] Ledipasvir and sofosbuvir:Interferon free therapy for hepatitis C virus genotype 1 infection
    Yasir Waheed
    World Journal of Virology, 2015, (01) : 33 - 35
  • [10] Ledipasvir-Sofosbuvir: A Once-Daily Oral Treatment Option for Chronic Hepatitis C Virus Genotype 1 Infection
    Jensen, Christopher M.
    Holle, Lisa M.
    PHARMACOTHERAPY, 2016, 36 (05): : 562 - 574
12345